![Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS](https://www.b3cnewswire.com/images/client_pictures/ElixirHealthPR/PR2/Thumbnail_PumaBiotech.png)
Puma Biotechnology Presents Final Overall Survival Analysis from the Phase III ExteNET Trial at the 2020 SABCS
![Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results - The AI Journal Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results - The AI Journal](https://aijourn.com/wp-content/uploads/2021/07/Business-Wire.jpeg)
Puma Biotechnology to Host Conference Call to Discuss Second Quarter Financial Results - The AI Journal
![Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News](https://cdn-news.warriortrading.com/wp-content/uploads/2017/07/19181629/PMYI.jpg)
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2020 Financial Results
![PDF) Synergistic Effect of Expressed miR-128 and Puma Protein on Targeted Induction of Tumor Cell Apoptosis PDF) Synergistic Effect of Expressed miR-128 and Puma Protein on Targeted Induction of Tumor Cell Apoptosis](https://i1.rgstatic.net/publication/308902843_Synergistic_Effect_of_Expressed_miR-128_and_Puma_Protein_on_Targeted_Induction_of_Tumor_Cell_Apoptosis/links/5840303708ae61f75dceda90/largepreview.png)
PDF) Synergistic Effect of Expressed miR-128 and Puma Protein on Targeted Induction of Tumor Cell Apoptosis
![PUMA facilitates EMI1-promoted cytoplasmic Rad51 ubiquitination and inhibits DNA repair in stem and progenitor cells | Signal Transduction and Targeted Therapy PUMA facilitates EMI1-promoted cytoplasmic Rad51 ubiquitination and inhibits DNA repair in stem and progenitor cells | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-021-00510-w/MediaObjects/41392_2021_510_Fig1_HTML.png)
PUMA facilitates EMI1-promoted cytoplasmic Rad51 ubiquitination and inhibits DNA repair in stem and progenitor cells | Signal Transduction and Targeted Therapy
![Pint-Pharma - Puma Biotechnology and Pint Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Latin America Pint-Pharma - Puma Biotechnology and Pint Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Latin America](https://www.pint-pharma.com/images/st_metanic/blog/blog-2.png)